CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem...

CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases /PRNewswire/ -- CORD:USE Cord Blood Bank - www.corduse.com - is pleased to announce that it has entered into an Equity and Exclusive Services Agreement with TianheA Stem Cell Biotechnologies, Inc. which has licensedA a series of patented technologies for the isolation of human cord blood-derived multipotent stem cells for possible clinical applications.A Tianhe is performing Phase I/II clinical trials in using Tianhe's Stem Cell Educator ... (more)

http://ift.tt/1rIoUmI